Posted by Michael Wonder on 19 Jun 2020
Recommendations made by the PBAC – May 2020 intracycle meeting
19 June 2020 - There is actually only one recommendation.
The PBAC recommended the PBS (Section 100 - Highly Specialised Drugs Program) (STREAMLINED) listing of methoxsalen, delivered as part of an extracorporeal photopheresis service for the treatment of patients with refractory erythrodermic stage III-IVa T4 M0 cutaneous T-cell lymphoma, either as monotherapy or in combination with peginterferon alfa-2a.
